PL2124638T3 - Kompozycja zwiększająca wydolność i jej zastosowanie - Google Patents

Kompozycja zwiększająca wydolność i jej zastosowanie

Info

Publication number
PL2124638T3
PL2124638T3 PL08712839T PL08712839T PL2124638T3 PL 2124638 T3 PL2124638 T3 PL 2124638T3 PL 08712839 T PL08712839 T PL 08712839T PL 08712839 T PL08712839 T PL 08712839T PL 2124638 T3 PL2124638 T3 PL 2124638T3
Authority
PL
Poland
Prior art keywords
performance enhancing
enhancing composition
composition
performance
enhancing
Prior art date
Application number
PL08712839T
Other languages
English (en)
Inventor
Jon Lundberg
Eddie Weitzberg
Original Assignee
Heartbeet Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39721497&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2124638(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Heartbeet Ltd. filed Critical Heartbeet Ltd.
Publication of PL2124638T3 publication Critical patent/PL2124638T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01D—COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM
    • C01D9/00—Nitrates of sodium, potassium or alkali metals in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL08712839T 2007-02-26 2008-02-26 Kompozycja zwiększająca wydolność i jej zastosowanie PL2124638T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0700520 2007-02-26
SE0700729 2007-03-22
EP08712839.3A EP2124638B1 (en) 2007-02-26 2008-02-26 Performance enhancing composition and use thereof

Publications (1)

Publication Number Publication Date
PL2124638T3 true PL2124638T3 (pl) 2017-07-31

Family

ID=39721497

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08712839T PL2124638T3 (pl) 2007-02-26 2008-02-26 Kompozycja zwiększająca wydolność i jej zastosowanie

Country Status (12)

Country Link
US (2) US9180140B2 (pl)
EP (2) EP3159000A1 (pl)
JP (1) JP2010519335A (pl)
CA (1) CA2678093C (pl)
CY (1) CY1118847T1 (pl)
DK (1) DK2124638T3 (pl)
ES (1) ES2618655T3 (pl)
HR (1) HRP20170355T1 (pl)
HU (1) HUE031982T2 (pl)
PL (1) PL2124638T3 (pl)
PT (1) PT2124638T (pl)
WO (1) WO2008105730A1 (pl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11759477B2 (en) 2007-02-26 2023-09-19 Heartbeet Ltd. Compositions of nitrates and methods of use thereof
AU2008219834C1 (en) 2007-02-26 2015-11-12 Heartbeet Ltd. New use of nitrites and nitrates and compositions containing these
US10842813B2 (en) 2007-02-26 2020-11-24 Heartbeet Ltd Compositions of nitrates and methods of use thereof
US10835555B2 (en) * 2007-02-26 2020-11-17 Heartbeet Ltd Compositions of nitrates and methods of use thereof
US10821132B2 (en) 2007-02-26 2020-11-03 Heartbeet Ltd Compositions of nitrates and methods of use thereof
US8466187B2 (en) 2007-09-18 2013-06-18 Thermolife International, Llc Amino acid compositions
US9649334B2 (en) 2007-11-15 2017-05-16 The Uab Research Foundation Use of nitrite salts in chronic ischemia
WO2010147742A2 (en) 2009-06-18 2010-12-23 Theravasc Inc. Use of nitrite salts in treating tissue damage
DE102009041425B4 (de) * 2009-08-13 2017-08-31 Aeroscan Gmbh Verfahren zur Steuerung eines Spiroergometriesystems und Spiroergometriesystem
JP5758904B2 (ja) 2009-10-14 2015-08-05 セラバスク インコーポレーテッド ニトライトの医薬製剤及びそれらの使用
WO2012142474A2 (en) 2011-04-13 2012-10-18 Thermolife International, Llc N-acetyl beta alanine methods of use
AU2012296358B2 (en) * 2011-08-17 2016-04-21 Board Of Regents, The University Of Texas System Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system
WO2013167982A1 (en) * 2012-05-07 2013-11-14 Nestec S.A. Puree compositions having specific carbohydrate ratios and methods for using same
AU2014218916A1 (en) 2013-02-20 2015-09-03 Theravasc Inc. Pharmaceutical formulations of nitrite and uses thereof
CA2902965C (en) * 2013-02-28 2023-08-29 Aires Pharmaceuticals, Inc. Inorganic nitrite to improve cardiopulmonary hemodynamics
CA2915396A1 (en) * 2013-06-13 2014-12-18 The Hershey Company Food compositions that enhance nitric oxide mediated signalling
US11338005B2 (en) 2013-06-28 2022-05-24 Arjuna Natural Private Limited Medicinal composition of amaranth origin for cardiovascular treatment
CA2916570A1 (en) 2013-06-28 2014-12-31 Benny Antony A medicinal composition of amaranth extract origin having enriched nitrate content and a method of preparing the same
US20160095341A1 (en) * 2014-06-13 2016-04-07 The Hershey Company Food compositions that enhance nitric oxide mediated signalling
JP2016032808A (ja) * 2014-07-30 2016-03-10 株式会社サンダーアーク 機能性飲料水及びその製造方法
EP3291691B1 (en) 2015-05-06 2023-06-07 YARA International ASA The use of nitrate for treating post-parturient dysgalactia in monogastric mammals
JP6833726B2 (ja) * 2015-05-27 2021-02-24 ヴィディエフ・フューチャースーティカルズ・インコーポレイテッドＶｄｆ Ｆｕｔｕｒｅｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 運動能力を高める組成物および方法
US11241406B2 (en) 2015-08-28 2022-02-08 Nature's Sunshine Products, Inc. Compositions and methods for acutley raising nitric oxide levels
US10362998B2 (en) 2016-02-25 2019-07-30 Samsung Electronics Co., Ltd. Sensor-based detection of changes in health and ventilation threshold
US11164596B2 (en) 2016-02-25 2021-11-02 Samsung Electronics Co., Ltd. Sensor assisted evaluation of health and rehabilitation
US10420514B2 (en) 2016-02-25 2019-09-24 Samsung Electronics Co., Ltd. Detection of chronotropic incompetence
US10172517B2 (en) 2016-02-25 2019-01-08 Samsung Electronics Co., Ltd Image-analysis for assessing heart failure
EP3442545A4 (en) 2016-04-11 2020-01-08 President and Fellows of Harvard College PROBIOTIC FORMULATIONS FOR IMPROVING SPORTS PERFORMANCE
WO2017214157A1 (en) 2016-06-06 2017-12-14 Theravasc Inc. Pharmaceutical formulations of nitrite uses thereof
AU2018237816A1 (en) 2017-03-23 2019-10-31 Mission Salt, Inc. Beetroot-containing composition
GB202004927D0 (en) 2020-04-03 2020-05-20 Sis Science In Sport Ltd Compositions
US11865139B2 (en) 2020-11-12 2024-01-09 Thermolife International, Llc Method of treating migraines and headaches
CN112772789B (zh) * 2020-12-31 2023-05-09 内江师范学院 石榴皮饲料用功能添加剂、制备方法及应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB962209A (en) * 1962-04-19 1964-07-01 Upjohn Co Multi-vitamin compositions containing fluorides
US4868179A (en) * 1987-04-22 1989-09-19 Cohn Jay N Method of reducing mortality associated with congestive heart failure using hydralazine and isosorbide dinitrate
CA2066951A1 (en) * 1991-04-26 1992-10-27 Kou Moriyama Edible composition
US5476847A (en) 1994-06-29 1995-12-19 Schering Corporation Derivatives of phosphinic acid useful as endothelin converting enzyme inhibitors
US20050036996A1 (en) * 1996-12-24 2005-02-17 Edmond Roussel Absorbable composition containing propionic bacteria capable of releasing nitric oxide in the human or animal alimentary canal
AU741439B2 (en) 1996-12-30 2001-11-29 Battelle Memorial Institute Formulation and method for treating neoplasms by inhalation
US6117872A (en) * 1998-06-23 2000-09-12 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of exercise performance by augmenting endogenous nitric oxide production or activity
EP1115389B1 (en) 1998-09-25 2014-03-12 PhilERA New Zealand Limited Fructosamine oxidase: antagonists and inhibitors
DE19913437B4 (de) * 1999-03-25 2009-05-14 Karl Müller GmbH & Co. Verwendung einer Umrötungsmischung
CA2383974A1 (en) 1999-09-08 2001-03-15 Nitromed Inc. Methods of treating and preventing congestive heart failure with hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
CA2427321A1 (en) * 2000-11-02 2003-04-03 The Lubrizol Corporation Stabilized energetic water in oil emulsion composition
KR20020057695A (ko) 2001-01-03 2002-07-12 류경열 야채 종합 비타민 강정제 제조방법
US20030036565A1 (en) * 2001-06-22 2003-02-20 Wisconsin Alumni Research Foundation Cancer chemopreventive agents
SE0203817D0 (sv) 2002-12-20 2002-12-20 Jon Lundberg New composition
KR100492083B1 (ko) * 2003-02-22 2005-06-01 삼성전자주식회사 화상형성장치의 급지 카세트
JP4100224B2 (ja) * 2003-04-07 2008-06-11 大正製薬株式会社 飲料組成物
JP5564158B2 (ja) 2003-07-09 2014-07-30 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ 亜硝酸塩によって特定の心臓血管状態を処置する方法
US20050226906A1 (en) * 2004-04-08 2005-10-13 Micro Nutrient, Llc Nutrient system for individualized responsive dosing regimens
US20050266018A1 (en) * 2004-05-27 2005-12-01 Boreyko Benson K Nutraceutical compositions with mangosteen
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
WO2006110601A2 (en) 2005-04-07 2006-10-19 Nitromed, Inc. The genetic risk assessment in heart failure: impact of the genetic variation of nos3
GB0522566D0 (en) 2005-11-04 2005-12-14 Novartis Ag Organic compounds
AU2008219834C1 (en) * 2007-02-26 2015-11-12 Heartbeet Ltd. New use of nitrites and nitrates and compositions containing these
US8303995B1 (en) * 2008-06-13 2012-11-06 Board Of Regents, The University Of Texas System Nitrite formulations and their use as nitric oxide prodrugs

Also Published As

Publication number Publication date
HUE031982T2 (en) 2017-08-28
US9180140B2 (en) 2015-11-10
EP2124638A4 (en) 2014-04-02
JP2010519335A (ja) 2010-06-03
US20100047344A1 (en) 2010-02-25
US10555968B2 (en) 2020-02-11
DK2124638T3 (en) 2017-03-20
PT2124638T (pt) 2017-03-13
HRP20170355T1 (hr) 2017-05-19
EP3159000A1 (en) 2017-04-26
EP2124638A1 (en) 2009-12-02
ES2618655T3 (es) 2017-06-21
US20150352147A1 (en) 2015-12-10
WO2008105730A1 (en) 2008-09-04
CY1118847T1 (el) 2018-01-10
EP2124638B1 (en) 2016-12-07
CA2678093A1 (en) 2008-09-04
CA2678093C (en) 2017-10-24

Similar Documents

Publication Publication Date Title
PL2124638T3 (pl) Kompozycja zwiększająca wydolność i jej zastosowanie
PT2114900T (pt) Compostos à base de tiopirimidina e as suas utilizações
ZA201001300B (en) Antigen-asjuvant compositions and methods
EP2128196A4 (en) POLYMERIC COMPOSITION AND APPLICATION THEREOF
EP2172524A4 (en) RESIN COMPOSITION AND USE THEREOF
GB0721291D0 (en) Methods and compositions
GB0717376D0 (en) Composition and manufacture thereof
EP2233528A4 (en) RUBBER COMPOSITION AND USE THEREOF
GB0719526D0 (en) Compositions and methods
GB0819432D0 (en) Compound, composition and use
EP1998753A4 (en) COMPOSITIONS FOR MAJOR DEPOSITION AND USES THEREOF
EP2247303A4 (en) HEMOSTASE MODULATING COMPOSITIONS AND USES THEREFOR
EP2133326A4 (en) NEW PSEUDOGLYCOLIPID AND ITS USE
GB0715428D0 (en) Compositions and uses thereof
EP2170874A4 (en) NEW COMPOUNDS AND THEIR USE
GB0701170D0 (en) Compositions and uses thereof
GB0718718D0 (en) Compound and use thereof
ZA201000357B (en) 2-Azetidinemethaneamines and 2-pyrrolidinemethaneamines as Taar-Ligands
GB0701171D0 (en) Compositions and uses thereof
GB0600336D0 (en) Composition and uses thereof
IL192820A0 (en) Novel compounds and use thereof
EP2010141A4 (en) HIGH DEPOSITION COMPOSITIONS AND USES THEREOF
GB0725264D0 (en) Compositions and uses thereof
ZA200807390B (en) Topical composition and use thereof
GB0708445D0 (en) Compounds and uses thereof